Absolute metabolite quantification by in vivo nmr spectroscopy: I. Introduction, objectives and activities of a concerted action in biomedical research

Magnetic Resonance Imaging

Volumn 16, Issue 9, 1998, Pages 1085-1092

  Podo, F ^a   Henriksen, O ^b   Bovee W M M J ^c   Leach, M O ^d   Leibfritz, D ^e   De Certaines, J D ^f  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b HVIDOVRE HOSPITAL   (Denmark)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e UNIVERSITY OF BREMEN   (Germany)

^f Universite de Rennes   (France)

Author keywords

Absolute quantification in MRS; Brain; Cancer; Data analysis; Magnetic resonance spectroscopic imaging (MRSI); Performance assessment; Standardization of methodologies

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ARTICLE; BODY FLUID; BRAIN DISEASE; CALIBRATION; CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; DATA ANALYSIS; EUROPEAN UNION; HUMAN; INTERMETHOD COMPARISON; LIPID METABOLISM; MEDICAL RESEARCH; METABOLITE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ASSAY; REPRODUCIBILITY; SIGNAL PROCESSING; VALIDATION PROCESS;

BRAIN; BRAIN NEOPLASMS; CALIBRATION; CLINICAL PROTOCOLS; DATA INTERPRETATION, STATISTICAL; EUROPE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MULTICENTER STUDIES; RESEARCH;

EID: 0032441609     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(98)00117-9     Document Type: Article

References (66)

1. Leach, M.O.; Arnold, D.; Brown, T.R.; Charles, H.C.; de Certaines, J.D.; Evelhoch, J.L.; Margulis, A.R.; Negendank, W.G.; Nelson, S.J.; Podo, F.; Styles, P.; Shtern, F. International Workshop on Standardization in Clinical MRS Measurements. Proceedings and Recommendations. (From the Diagnostic Imaging Research Branch, The NCI, F. Shtern, Ed.)
2. (a) Acad. Radiol. 1:171-186; 1994;
3. (b) Technology and Health Care 2:217-234; 1994;
4. (c) In: F. Podo et al., Eds. Eurospin Annual 1994. Rome: Istituto Superiore di Sanità, 1994: pp. 171-233.
5. Podo F., Bovée W.M.M.J., de Certaines J.D., Leibfritz D., Orr J.S. Quality assessment in in vivo NMR spectroscopy. I. Introduction, objectives and activities. Magn. Reson. Imaging. 13:1995;117-121.
6. 1H MRS in vivo in brain tumors Experience of the Siemens cooperative clinical trial . Anticancer Res. 16:1996;1533-1538.
7. Negendank W., Sauter R., Brown T.R., Evelhoch J.L., Falini A., Gotsis E.D., Heerschap A., Kameda K., Lee B.C.P., Mangeot M.M., Moser E., Padavic-Shaller K.A., Saunders J.A., Spraggins T.A., Stillman A.E., Terwey B., Vogl T.J., Wicklow K., Zimmermann R.A. Proton MR spectroscopy in patients with glial tumors A multicentre study . J. Neurosurgery. 84:1996;449-458.
8. Podo F. Tissue characterization by MRI a multidisciplinary and multi-centre challenge today (Special Editorial) . Magn. Reson. Imaging. 6:1988;173-174.
9. Identification and Characterization of Biological Tissues by NMR. Concerted Research Project of the European Community: (a) Podo, F.; Orr, J.S.; Schmidt, K.H.; Bovée, W.M.M.J. I. Introduction, objectives, and activities. Magn. Reson. Imaging 6:175-178; 1988;
10. (b) EEC Concerted Research Project. II. A protocol for in vitro proton relaxation studies. Magn. Reson. Imaging 6:179-184; 1988;
11. (c) Mathur-De Vré, R.; Binet, J.; Bovée, W.M.M.J.; Foster, M.A. III. Multi-center trial with an in vitro NMR protocol. Magn. Reson. Imaging 6:185-194; 1988;
12. (d) EEC Concerted Research Project. IV. Protocols and test objects for the assessment of MRI equipment. Magn. Reson Imaging 6:195-199; 1988;
13. (e) Lerski, R.A.; McRobbie, D.W.; Straughan, K.; Walker, P.M.; de Certaines, J.D. and Bernard, A.M. V. Multi-center trial with protocols and prototype test objects for the assessment of MRI equipment. Magn. Reson. Imaging 6:201-214; 1988;
14. (f) Walker, P.; Lerski, R.A.; Mathur-De Vré, R.; Binet J.; Yane, F. VI. Preparation of agarose gels as reference substances for NMR relaxation time measurement. Magn. Reson. Imaging 6:215-222; 1988.
15. Tissue Characterization by Magnetic Resonance Spectroscopy and Imaging: Results of a Concerted Research Project of the European Community. (a) Podo, F.; Orr, J.S.; Bovée, W.M.M.J.; de Certaines, J.D.; Leibfritz, D. I. Introduction, objectives, and activities. Magn. Reson. Imaging 11:809-815; 1993;
16. (b) Lerski R.A.; de Certaines, J.D. II. Performance assessment and quality control in MRI by Eurospin test objects and protocols. Magn. Reson. Imaging 11:817-833; 1993;
17. (c) Lerski, R.A. III. Trial of modifications to Eurospin MRI test objects. Magn. Reson. Imaging 11:835-839, 1993;
18. (d) de Certaines; J.D.; Henriksen, O.; Spisni, A.; Cortsen, M.; Ring, P.B. IV. In vivo measurements of proton relaxation times in human brain, liver, and skeletal muscle: a multicentre MRI study. Magn. Reson. Imaging 11:841-850; 1993;
19. (e) Henriksen, O.; de Certaines, J.D.; Spisni, A.; Cortsen, M.; Müller, R.N.; Ring, P.B. V. In vivo field dependence of proton relaxation times in human brain, liver, and skeletal muscle: A multicentre study. Magn. Reson. Imaging 11:851-856; 1993;
20. (f) Ring, P.B.; Jenson, J.A.; Henriksen, O. VI. A software program for exchange MR data. Magn. Reson. Imaging 11:857-864;1993;
21. (g) Moser, E.; Orr, J.S.: Podo, F.; Lendinara, L.; Canese, R. VII. Analysis of the first international data bank on in vitro NMR relaxation times: Animal liver. Magn. Reson. Imaging 11:865-872; 1993;
22. (h) Lerski, R.A.; Straughan, K.; Schad, L.R.; Boyce, D.; Blüml S.; Zuna, I. VIII. MR image texture analysis - An approach to tissue characterization. Magn. Reson. Imaging 11:873-887; 1993.
23. Podo F. Tissue characterization by magnetic resonance spectroscopy (MRS). Advan. Biomed. Engin. 7:1993;304-317.
24. Podo F., Orr J.S. Tissue characterization by magnetic resonance spectroscopy and imaging. 1992;Istituto Superiore di Sanità Rome.
25. de Certaines J.D., Bovée W.M.M.J., Podo F. Magnetic resonance spectroscopy in biology and medicine. 1992;Pergamon Press, Oxford.
26. Podo F., Bovée W.M.M.J., de Certaines J.D., Henriksen O., Leach M.O., Leibfritz D. Eurospin Annual 1994. (ISBN 88-9000028-1-6). 1994;Istituto Superiore di Sanità Rome.
27. Podo F., Bovée W.M.M.J., de Certaines J.D., Henriksen O., Leach M.O., Leibfritz D. Eurospin Annual 1995-1996. (ISBN 88-900028-2-4). 1996;Istituto Superiore di Sanità Rome.
28. Quality Assessment in In Vivo NMR Spectroscopy: Results of a Concerted Research Project of the European Economic Community. (a) EEC Concerted Research Project. II. A protocol for quality control assessment. Magn. Reson. Imaging 13:123-129; 1995;
29. (b) Leach, M.O.; Collins, D.J.; Keevil, S.F.; Rowland, I.; Smith, M.A.; Henriksen, O.; Bovée, W.M.M.J.; Podo, F. III. Clinical test objects: Design, construction and solutions. Magn. Reson. Imaging 13:131-137; 1995;
30. (c) Keevil, S.F.; Barbiroli, B.; Collins, D.J.; Danielsen, E.R.; Hennig, J.; Henriksen, O.; Bovée W.M.M.J.; Podo, F. IV. A multicentre trial of test objects and protocols for performance assessment in clinical NMR spectroscopy. Magn. Reson. Imaging 13:139-157; 1995;
31. (d) Howe, F.; Canese, R.; Podo, F.; Vikhoff, B.; Slotboom, J.; Griffiths, J.R.; Henriksen O.; Bovée, W.M.M.J. V. Multicentre evaluation of prototype test objects and protocols for performance assessment in small bore MRS equipment. Magn. Reson. Imaging 13:159-167; 1995;
32. (e) de Beer, R.; Bachert-Baumann, P.; Bovée, W.M.M.J.; Cady, E.; Chambron, J.; Dommisse, R.; van Echteld, C.J.A.; Mathur-De Vré, R.A.; Williams, S.R. VI. Multicentre quantification of MRS test signals. Magn. Reson. Imaging 13:169-176; 1995.
33. Podo F., Bovée W.M.M.J., Orr J.S. Whole body machines quality control . Grant D.M., Harris R.K. Encyclopedia of NMR. 1996;4990-4995 Wiley, Chichester, PA.
34. Henriksen O. In Vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed. 8:1995;139-148. (Review paper).
35. 1H MRS spectrometers. Podo et al F. Eurospin Annual 1995-1996. 1996;242-254 Istituto Superiore di Sanita, Rome.
36. Cady E.B. Quantification of metabolites in human brain by proton magnetic resonance spectroscopy; Methodologies, limitations and achievements. Podo et al F. Eurospin Annual 1995-1996. 1996;17-40 Istituto Superiore di Sanità Rome.
37. 1H MRS using water as an internal standard. Magn. Reson. Imaging. 11:1993;107-118.
38. Michaelis T., Merboldt K.D., Bruhn H., Hänicke W., Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo Quantification of localized proton MR spectra . Radiology. 187:1993;219-227.
39. 31P MRS. NMR Biomed. 7:1994;225-230.
40. Ernst T., Kreis R., Ross B.D. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J. Magn. Reson. B. 102:1993;1-8.
41. Kreis R., Ernst T., Ross B.D. Absolute quantitation of water and metabolites in the human brain. II.: Metabolite concentrations. J. Magn. Reson. B. 102:1993;9-19.
42. Keevil, S.F.; Barbiroli, B.; Brooks, J.C.W.; Cady, E.B.; Canese, R.; Carlier, P.; Collins, D.J.; Gilligan, P.; Gobbi, G.; Hennig, J.; Kügel, H.; Leach, M.O.; Metzler, D.; Mlynárik, V.; Moser, E.; Newbold, M.C.; Payne, G.S.; Ring, P.; Roberts, J.N.; Rowland, I.J.; Thiel, T.; Tkác, I.; Topp, S.; Wittsack, H.-J.; Wylezinska, M.; Zaniol, P.; Henriksen O. and Podo, F. Absolute metabolite quantification by magnetic resonance spectroscopy: II. A multicentre trial of protocols for in vivo localized proton studies of human brain. Magn. Reson. Imaging. 16:1093-1106; 1998.
43. 1H MRS of the human brain addressed by one and the same data-analysis protocol . Magn. Reson. Imaging. 16:1998;1107-1111.
44. Brown T.R., Kincaid B.M., Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl.Acad. Sci. USA. 79:1982;3523-3526.
45. Maudsley A.A., Hilal S.K., Perman W.H., Simon H.E. Spatially resolved high resolution spectroscopy by four-dimensional NMR. J. Magn. Reson. 51:1983;147-152.
46. Decorps M., Dupeyre R., Remy C., Le Fur Y., Devoulon P., Bourgeois D. Spectroscopic Imaging. de Certaines J.D., Bovée W.M.M.J., Podo F. Magnetic resonance spectroscopy in biology and medicine. 1992;111-132 Pergamon Press, Oxford.
47. Bovée W.M.M.J., Canese R., Decorps M., Forssell-Aronsson E., Le Fur Y., Howe F., Karlsen O., Knijn A., Kontaxis G., Kügel H., McLean M., Podo F., Slotboom J., Vikhoff B., Ziegler A. Absolute metabolite quantification by Magnetic Resonance Spectroscopy: IV. Multicentre trial on MRSI localisation tests. Magn. Reson. Imaging. 16:1998;1113-1125.
48. de Beer R., Van den Boogaart A., Cady E.B., Graveron-Demilly D., Knijn A., Langenberger K.W., Lindon J.D., Olhoff A., Serraî H., Wylezinska-Arridge M. Absolute metabolite quantification by magnetic resonance spectroscopy: V. Multicentre quantitative data-analysis trial on the overlapping background problem. Magn. Reson. Imaging. 16:1998;1127-1136.
49. 1H NMR spectroscopy. J. Magn. Reson. Analysis. 2:1996;66-74.
50. Griffiths, J.R.; Maxwell, R.J.; Howells, S.L. A multi-centre trial on MR spectroscopy of human tissue biopsies. In: F. Podo et al., (Eds.). Eurospin Annual 1995-1996. Rome: Istituto Superiore di Sanità; 1996: pp. 295-316.
51. 1H NMR spectra from human brain tumor biopsies. 3rd SMR and 12th ESMRMB Joint Annual Meeting. Nice, August 19-25, Book of Abstracts. 3:1709;
52. 1H NMR spectra from human brain tumour biopsies. Anticancer Res. 15:1701; 1995;
53. 1H NMR biopsy spectra. 4th ISMRM Annual Meeting, New York, 27 April-3 May 1996, book of Abstracts. 1:411; 1996.
54. 1H nuclear magnetic resonance spectra by the application of chemometric techniques. Magn. Reson. Med. 28:1992;214-236.
55. 31P magnetic resonance spectroscopy tumour spectra obtained in vivo. NMR Biomed. 6:1993;237-241.
56. 1H NMR spectra from perchloric acid extracts of human brain tumour biopsies. Magn. Reson. Med. 39:869-877; 1998.
57. Special Symposium of "Lipid Metabolism and Function in Cancer. Significance of Magnetic Resonance Spectroscopy (MRS) Measurements in Relation to Biochemical Processes and Cellular Control," Abstracts of the Fifth International Conference of Anticancer Research, Corfu, October 17-22, 1995. Anticancer Res. 15:1684-1711; 1995.
58. Podo F. and de Certaines J.D. (Eds.). Proceedings of the Special Symposium on "Lipid Metabolism and Function in Cancer. Significance of Magnetic Resonance Spectroscopy (MRS) Measurements in Relation to Biochemical Processes and Cellular Control," Corfu, 18-20 October 1995. Anticancer Res. 16:1305-1594; 1996.
59. (a)Leach, M.O. Evaluation of drug pharmacokinetics and metabolism using MRS. In: F. Podo et al., (Eds.). Eurospin Annual 1995-1996. Rome: Istituto Superiore di Sanità; 1996: pp. 51-52;
60. 19F MRS. Ibidem, pp. 53-61;
61. 19F NMR for the study of metabolism and toxicity of the anticancer drug, 5-fluorouracil. Ibidem, pp. 62-66;
62. 19F MR. Ibidem., pp. 66-72;
63. (e) Maxwell, R.J. In vivo nuclear magnetic resonance spectroscopy for pharmacokinetics measurements. Ibidem, 73-81;
64. (f) Leach, M.O. Evaluation of fluoropyrimidine activity by in vivo magnetic resonance spectroscopy. Ibidem, pp. 82-91;
65. 19F NMR spectroscopy. Ibidem, pp. 92-98;
66. 19F NMR spectroscopy. Ibidem, pp. 99-103.